Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited ...

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down ...

CARVYKTI is a B-cell maturation antigen-targeted therapy for treating patients with multiple myeloma. Credit: Shidlovski/Shutterstock. Health Canada has issued a notice of compliance (NOC) for Johnson ...

Technology has changed the clinical trial landscape forever, with application programming interfaces (APIs) growing in ...

RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.

Events like the RFK Jr nomination as US HHS head, Labour’s 10-year plan, and centralised EU funding will steer the sector’s ...

TV personality Dr Oz has been nominated by President-elect Donald Trump to lead the Centers for Medicare and Medicaid ...

HYMPAVZI is a once-weekly subcutaneous treatment option for individuals with severe haemophilia A or B. Credit: ...

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.